165 related articles for article (PubMed ID: 15750166)
1. Antisense targeting of p-glycoprotein expression in tissue culture.
Nakamura K; Kubo A; Hnatowich DJ
J Nucl Med; 2005 Mar; 46(3):509-13. PubMed ID: 15750166
[TBL] [Abstract][Full Text] [Related]
2. Evidence of antisense tumor targeting in mice.
Nakamura K; Fan C; Liu G; Gupta S; He J; Dou S; Kubo A; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2004; 15(6):1475-80. PubMed ID: 15546217
[TBL] [Abstract][Full Text] [Related]
3. Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker.
Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ
J Nucl Med; 2007 Nov; 48(11):1845-52. PubMed ID: 17978353
[TBL] [Abstract][Full Text] [Related]
4. Initial mechanistic studies of antisense targeting in cells.
Liu X; Nakamura K; Wang Y; Wang Y; Liu G; He J; Ding H; Lu P; Rusckowski M; Kubo A; Hnatowich DJ
J Nucl Med; 2006 Feb; 47(2):360-8. PubMed ID: 16455644
[TBL] [Abstract][Full Text] [Related]
5. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
Crankshaw CL; Marmion M; Luker GD; Rao V; Dahlheimer J; Burleigh BD; Webb E; Deutsch KF; Piwnica-Worms D
J Nucl Med; 1998 Jan; 39(1):77-86. PubMed ID: 9443741
[TBL] [Abstract][Full Text] [Related]
6. In vitro investigations of tumor targeting with (99m)Tc-labeled antisense DNA.
Zhang YM; Wang Y; Liu N; Zhu ZH; Rusckowski M; Hnatowich DJ
J Nucl Med; 2001 Nov; 42(11):1660-9. PubMed ID: 11696636
[TBL] [Abstract][Full Text] [Related]
7. Cationic transfectors increase accumulation in cultured tumor cells of radiolabeled antisense DNAs without entrapment.
Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ
Cancer Biother Radiopharm; 2007 Oct; 22(5):629-35. PubMed ID: 17979565
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
[TBL] [Abstract][Full Text] [Related]
10. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
Nadali F; Pourfathollah AA; Alimoghaddam K; Nikougoftar M; Rostami S; Dizaji A; Azizi E; Zomorodipour A; Ghavamzadeh A
Hematology; 2007 Oct; 12(5):393-401. PubMed ID: 17852455
[TBL] [Abstract][Full Text] [Related]
12. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
14. (99m)Tc-MIBI imaging for prediction of therapeutic effects of second-generation MDR1 inhibitors in malignant brain tumors.
Sasajima T; Shimada N; Naitoh Y; Takahashi M; Hu Y; Satoh T; Mizoi K
Int J Cancer; 2007 Dec; 121(12):2637-45. PubMed ID: 17708555
[TBL] [Abstract][Full Text] [Related]
15. In vitro detection of mdr1 mRNA in murine leukemia cells with 111In-labeled oligonucleotide.
Bai J; Yokoyama K; Kinuya S; Shiba K; Matsushita R; Nomura M; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1523-9. PubMed ID: 15449049
[TBL] [Abstract][Full Text] [Related]
16. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
17. Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging.
Wang JH; Scollard DA; Teng S; Reilly RM; Piquette-Miller M
J Nucl Med; 2005 Sep; 46(9):1537-45. PubMed ID: 16157538
[TBL] [Abstract][Full Text] [Related]
18. [Reversal of multidrug resistance in lung adenocarcinoma-resistant cell line A549/R by mdr1 antisense oligodeoxynucleotides in vitro].
Chen L; Liu Y
Zhonghua Yi Xue Za Zhi; 2000 Mar; 80(3):219-21. PubMed ID: 11798761
[TBL] [Abstract][Full Text] [Related]
19. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
Fu P; Shen B; Zhao C; Tian G
J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
